391 related articles for article (PubMed ID: 37676590)
21. Strategy of computer-aided drug design.
Veselovsky AV; Ivanov AS
Curr Drug Targets Infect Disord; 2003 Mar; 3(1):33-40. PubMed ID: 12570731
[TBL] [Abstract][Full Text] [Related]
22. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
Hudson IL
Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
[TBL] [Abstract][Full Text] [Related]
23. A Review on Applications of Computational Methods in Drug Screening and Design.
Lin X; Li X; Lin X
Molecules; 2020 Mar; 25(6):. PubMed ID: 32197324
[TBL] [Abstract][Full Text] [Related]
24. Application of
Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
[TBL] [Abstract][Full Text] [Related]
25. Artificial intelligence in drug design.
Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
[TBL] [Abstract][Full Text] [Related]
26. A compact review of progress and prospects of deep learning in drug discovery.
Li H; Zou L; Kowah JAH; He D; Liu Z; Ding X; Wen H; Wang L; Yuan M; Liu X
J Mol Model; 2023 Mar; 29(4):117. PubMed ID: 36976427
[TBL] [Abstract][Full Text] [Related]
27. The Use of Methods of Computer-Aided Drug Discovery in the Development of Topoisomerase II Inhibitors: Applications and Future Directions.
Radaeva M; Dong X; Cherkasov A
J Chem Inf Model; 2020 Aug; 60(8):3703-3721. PubMed ID: 32687346
[TBL] [Abstract][Full Text] [Related]
28. Machine learning in computational docking.
Khamis MA; Gomaa W; Ahmed WF
Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
[TBL] [Abstract][Full Text] [Related]
29. The Use of Dynamic Pharmacophore in Computer-Aided Hit Discovery: A Case Study.
Perricone U; Wieder M; Seidel T; Langer T; Padova A
Methods Mol Biol; 2018; 1824():317-333. PubMed ID: 30039416
[TBL] [Abstract][Full Text] [Related]
30. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
31. Deep Learning in Structure-Based Drug Design.
Anighoro A
Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
[TBL] [Abstract][Full Text] [Related]
32. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
33. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
[TBL] [Abstract][Full Text] [Related]
34. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
35. The compromise of virtual screening and its impact on drug discovery.
Slater O; Kontoyianni M
Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
[No Abstract] [Full Text] [Related]
36. Deep learning tools for advancing drug discovery and development.
Nag S; Baidya ATK; Mandal A; Mathew AT; Das B; Devi B; Kumar R
3 Biotech; 2022 May; 12(5):110. PubMed ID: 35433167
[TBL] [Abstract][Full Text] [Related]
37. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
[TBL] [Abstract][Full Text] [Related]
38. In silico drug discovery approaches on grid computing infrastructures.
Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
[TBL] [Abstract][Full Text] [Related]
39. Computational Methodologies in the Exploration of Marine Natural Product Leads.
Pereira F; Aires-de-Sousa J
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30011882
[TBL] [Abstract][Full Text] [Related]
40. Systematic generation of chemical structures for rational drug design based on QSAR models.
Funatsu K; Miyao T; Arakawa M
Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
